Kowa Research Europe

Kowa Research Europe is the European research and development arm of the Japanese conglomerate Kowa Company, Ltd. Based in the United Kingdom, the company focuses on the clinical development, regulatory affairs, and pharmacovigilance of Kowa's pharmaceutical portfolio within the European market. Its primary therapeutic focus lies in cardiometabolic health, notably managing the development and lifecycle of the statin pitavastatin. Additionally, the company is active in the fields of ophthalmology and metabolic disorders. Kowa Research Europe plays a critical role in bridging Japanese drug development with European clinical standards and regulatory requirements.